Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-22 Sale | 2022-08-24 8:22 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | RAMSAY DAVID A Director | 100,000 | $6.23 | $623,000 | 0 (Direct) | View |
| 2022-08-22 Sale | 2022-08-24 8:20 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 11,969 | $6.23 | $74,567 | 0 (Direct) | View |
| 2022-08-22 Sale | 2022-08-24 8:18 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | Johnson Laura L. Director | 500 | $6.23 | $3,115 | 0 (Direct) | View |
| 2022-08-22 Sale | 2022-08-24 8:17 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | Johnson Craig A Director | 12,000 | $6.23 | $74,760 | 0 (Direct) | View |
| 2022-08-22 Sale | 2022-08-24 8:17 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 10,186 | $6.23 | $63,459 | 0 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-22 Equity Swap | 2022-08-24 8:21 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C Director 10% Owner | 9,607,934 | $6.23 | 0 (Indirect) | View |
| 2022-08-22 Equity Swap | 2022-08-24 8:21 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C Director 10% Owner | 3,519 | $0 | 0 (Indirect) | View |
| 2022-08-22 Equity Swap | 2022-08-24 8:19 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 3,519 | $0 | 0 (Indirect) | View |
| 2022-08-22 Equity Swap | 2022-08-24 8:17 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 9,607,934 | $6.23 | 0 (Indirect) | View |
| 2022-08-22 Equity Swap | 2022-08-24 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 9,607,934 | $6.23 | 0 (Indirect) | View |
| 2022-08-22 Equity Swap | 2022-08-24 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 3,519 | $0 | 0 (Indirect) | View |
| 2022-07-08 Exercise | 2022-07-12 8:36 pm | N/A 2029-12-20 | LA JOLLA PHARMACEUTICAL CO | LJPC | Johnson Craig A Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-07-08 Exercise | 2022-07-12 8:36 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Johnson Craig A Director | 12,000 | $3.93 | 12,000 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 5:51 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 236 | $2.7115 | 9,618,356 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 5:51 pm | N/A 2032-06-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 236 | $0 | 9,618,356 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 236 | $2.72 | 9,618,120 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:05 pm | N/A 2032-06-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 236 | $0 | 9,618,120 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 189 | $3.4085 | 9,617,837 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 5:05 pm | N/A 2032-05-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 189 | $0 | 9,617,837 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-17 5:07 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 188 | $3.4085 | 9,617,647 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-17 5:07 pm | N/A 2032-05-13 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 188 | $0 | 9,617,647 (Direct) | View |
| 2022-04-29 Option Award | 2022-05-03 5:00 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 185 | $3.468 | 9,617,456 (Direct) | View |
| 2022-04-29 Option Award | 2022-05-03 5:00 pm | N/A 2032-04-29 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 185 | $0 | 9,617,456 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-18 6:32 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 296 | $3.7145 | 12,265 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-18 6:32 pm | N/A 2032-04-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 296 | $0 | 12,265 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-18 6:31 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 173 | $3.7145 | 9,617,259 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-18 6:31 pm | N/A 2032-04-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 173 | $0 | 9,617,259 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 5:39 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 334 | $3.6295 | 12,007 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 5:39 pm | N/A 2032-03-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 334 | $0 | 12,007 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 5:38 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 177 | $3.6295 | 9,617,090 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 5:38 pm | N/A 2032-03-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 177 | $0 | 9,617,090 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 9:06 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 361 | $3.366 | 11,700 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 9:06 pm | N/A 2032-03-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 361 | $0 | 11,700 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 9:04 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 190 | $3.366 | 9,616,926 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 9:04 pm | N/A 2032-03-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 190 | $0 | 9,616,926 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 5:08 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 350 | $3.4765 | 11,328 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 5:08 pm | N/A 2032-02-28 | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 350 | $0 | 11,328 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 5:07 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 185 | $3.4765 | 9,616,731 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 5:07 pm | N/A 2032-02-28 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 185 | $0 | 9,616,731 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:10 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 320 | $3.791 | 10,948 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:10 pm | N/A 2032-02-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 320 | $0 | 10,948 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 169 | $3.791 | 9,616,530 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:05 pm | N/A 2032-02-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 169 | $0 | 9,616,530 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 7:21 pm | N/A 2032-01-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 4,170 | $0 | 14,478 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 7:21 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 4,170 | $3.9355 | 14,478 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 7:19 pm | N/A 2032-01-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 1,675 | $0 | 9,617,867 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 7:19 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 1,675 | $3.9355 | 9,617,867 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 8:27 pm | N/A 2032-01-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 273 | $0 | 6,411 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 8:27 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 273 | $4.182 | 6,411 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 8:26 pm | N/A 2032-01-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 148 | $0 | 9,614,665 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 8:26 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 148 | $4.182 | 9,614,665 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-14 9:00 pm | N/A 2032-01-12 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rosen Robert Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-14 9:00 pm | N/A 2032-01-12 | LA JOLLA PHARMACEUTICAL CO | LJPC | RAMSAY DAVID A Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-14 9:00 pm | N/A 2032-01-12 | LA JOLLA PHARMACEUTICAL CO | LJPC | Johnson Craig A Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-14 9:00 pm | N/A 2032-01-12 | LA JOLLA PHARMACEUTICAL CO | LJPC | Johnson Laura L. Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-14 6:29 pm | N/A 2032-01-12 | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 418,944 | $0 | 418,944 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-14 6:27 pm | N/A 2032-01-12 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 78,552 | $0 | 78,552 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-14 4:05 pm | N/A 2032-01-12 | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C Director 10% Owner | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-12-30 Option Award | 2022-01-04 5:10 pm | N/A 2031-12-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 233 | $0 | 6,098 (Direct) | View |
| 2021-12-30 Option Award | 2022-01-04 5:10 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 233 | $3.9185 | 6,098 (Direct) | View |
| 2021-12-30 Option Award | 2022-01-04 5:05 pm | N/A 2031-12-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 157 | $0 | 9,614,526 (Direct) | View |
| 2021-12-30 Option Award | 2022-01-04 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 157 | $3.9185 | 9,614,526 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 6:01 pm | N/A 2031-12-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 320 | $0 | 5,952 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 6:01 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Edwards Larry G. Chief Executive Officer | 320 | $3.5785 | 5,952 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 5:58 pm | N/A 2031-12-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 173 | $0 | 9,614,385 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 5:58 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 173 | $3.5785 | 9,614,385 (Direct) | View |